The S&P 500 (^GSPC) has entered correction, falling 10% from its February all-time highs as political uncertainty has driven ...

UiPath (NYSE:PATH – Free Report) had its price target reduced by BMO Capital Markets from $16.00 to $11.50 in a report ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its target price boosted by equities researchers at BMO Capital ...

Downbeat retail sales data and Treasury Secretary Scott Bessent's comments are adding to worries about the economy.

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

U.S. services sector growth unexpectedly picked up in February and prices for inputs increased, which combined with a recent ...

NFI Group Inc. ( NFI-T) stock could see a big move today after the Winnipeg-based bus maker said it swung to a profit in the ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of $12 ...

On Friday, BMO Capital Markets maintained its "Market Perform" rating and a $25.00 price target for Gap Inc. (NYSE:GAP) shares, above the current trading price of $19.48. According to InvestingPro ...

U.S. government debt rallied aggressively overnight and into Tuesday’s trading session, pushing yields below key technical levels in a way that appeared to be shaking confidence in the broader market.